Market Overview:
The global amyotrophic lateral sclerosis treatment market size reached US$ 681.7 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 962.08 Million by 2027, exhibiting a growth rate (CAGR) of 5.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Amyotrophic Lateral Sclerosis Treatment (ALS) refers to a degenerative disease that affects the nerve cells in the spinal cord and brain, resulting in loss of muscle control. It primarily occurs due to gene mutation, disorganized immune response, chemical imbalance, etc. Some of the common symptoms of ALS include muscle stiffness, twitching of the muscles, weakness in the legs or arms, cognitive and behavioral changes, trouble in swallowing, slurred speech, etc. The diagnosis of ALS relies on medical history, physical examination, electrodiagnostic testing, and neuroimaging.
Amyotrophic Lateral Sclerosis Treatment Market Trends:
The rising incidences of neurodegenerative disorders due to changing lifestyle patterns and hectic schedules of the individuals are primarily driving the Amyotrophic Lateral Sclerosis Treatment treatment market. Besides this, the expanding geriatric population, who are more susceptible to such neurological ailments, is also augmenting the market growth. Furthermore, several NGOs and private organizations are undertaking numerous initiatives to increase awareness regarding the diagnosis and treatment of ALS among the masses. This, in turn, is creating a positive outlook for the market. Additionally, the growing penetration of targeted and symptomatic treatment options for ALS is acting as a significant growth-inducing factor. Moreover, the elevating focus on clinical trials and faster approval of oral drugs for ALS treatment is also bolstering the market growth. Moreover, the increasing strategic collaborations among various research institutes to develop innovative treatment procedures that aim at enhancing muscle function, immune modulation, and neuroprotection are further catalyzing the global market. In the coming years, the continuous upgradation of healthcare infrastructures along with elevating penetration of refurbishment policies will continue to drive the global Amyotrophic Lateral Sclerosis Treatment (ALS) market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global amyotrophic lateral sclerosis treatment market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on treatment and distribution channel.
Breakup by Treatment:
- Medication
- Stem Cell Therapy
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AB Science, Ascend Pharmaceuticals LLC, BrainStorm Cell Therapeutics Inc., Corestem Inc., Cytokinetics Inc., Eledon Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., ITF Pharma (Italfarmaco S.p.A), Mitsubishi Chemical Group Corpotion, Revalesio Corporation and Treeway B.V.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Million |
| Segment Coverage |
Treatment, Distribution Channel, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
AB Science, Ascend Pharmaceuticals LLC, BrainStorm Cell Therapeutics Inc., Corestem Inc., Cytokinetics Inc., Eledon Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., ITF Pharma (Italfarmaco S.p.A), Mitsubishi Chemical Group Corpotion, Revalesio Corporation and Treeway B.V. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global amyotrophic lateral Sclerosis treatment market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global amyotrophic lateral sclerosis treatment market?
- What are the key regional markets?
- What is the breakup of the market based on the treatment?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global amyotrophic lateral sclerosis treatment market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Amyotrophic Lateral Sclerosis Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Treatment
6.1 Medication
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Stem Cell Therapy
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Distribution Channel
7.1 Hospital Pharmacies
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Retail Pharmacies
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 AB Science
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Ascend Pharmaceuticals LLC
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.3 BrainStorm Cell Therapeutics Inc.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.4 Corestem Inc.
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.5 Cytokinetics Inc.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 Eledon Pharmaceuticals Inc.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.7 Ionis Pharmaceuticals Inc.
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 ITF Pharma (Italfarmaco S.p.A)
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.9 Mitsubishi Chemical Group Corpotion
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Revalesio Corporation
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.11 Treeway B.V.
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
List of Figures
Figure 1: Global: Amyotrophic Lateral Sclerosis Treatment Market: Major Drivers and Challenges
Figure 2: Global: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Treatment (in %), 2021
Figure 5: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Distribution Channel (in %), 2021
Figure 6: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Region (in %), 2021
Figure 7: Global: Amyotrophic Lateral Sclerosis Treatment (Medication) Market: Sales Value (in Million US$), 2016 & 2021
Figure 8: Global: Amyotrophic Lateral Sclerosis Treatment (Medication) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 9: Global: Amyotrophic Lateral Sclerosis Treatment (Stem Cell Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Amyotrophic Lateral Sclerosis Treatment (Stem Cell Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Amyotrophic Lateral Sclerosis Treatment (Other Treatments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Amyotrophic Lateral Sclerosis Treatment (Other Treatments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Amyotrophic Lateral Sclerosis Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Amyotrophic Lateral Sclerosis Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Amyotrophic Lateral Sclerosis Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Amyotrophic Lateral Sclerosis Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Amyotrophic Lateral Sclerosis Treatment (Other Distribution Channels) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Amyotrophic Lateral Sclerosis Treatment (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: North America: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: North America: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: United States: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: United States: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Canada: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Canada: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Asia-Pacific: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Asia-Pacific: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: China: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: China: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Japan: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Japan: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: India: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: India: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: South Korea: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: South Korea: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Australia: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Australia: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Indonesia: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Indonesia: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Others: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Others: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Europe: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Europe: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Germany: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Germany: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: France: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: France: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: United Kingdom: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: United Kingdom: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Italy: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Italy: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Spain: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Spain: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Russia: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Russia: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Others: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Others: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Latin America: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Latin America: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Brazil: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Brazil: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Mexico: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Mexico: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Others: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Others: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Middle East and Africa: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Middle East and Africa: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Country (in %), 2021
Figure 67: Middle East and Africa: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Global: Amyotrophic Lateral Sclerosis Treatment Industry: SWOT Analysis
Figure 69: Global: Amyotrophic Lateral Sclerosis Treatment Industry: Value Chain Analysis
Figure 70: Global: Amyotrophic Lateral Sclerosis Treatment Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Amyotrophic Lateral Sclerosis Treatment Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by Treatment (in Million US$), 2022-2027
Table 3: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 4: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 5: Global: Amyotrophic Lateral Sclerosis Treatment Market: Competitive Structure
Table 6: Global: Amyotrophic Lateral Sclerosis Treatment Market: Key Players